WO2004022657A8 - Verstärkung der resorption von substanzen über die haut und schleimhaut - Google Patents
Verstärkung der resorption von substanzen über die haut und schleimhaut Download PDFInfo
- Publication number
- WO2004022657A8 WO2004022657A8 PCT/EP2003/009788 EP0309788W WO2004022657A8 WO 2004022657 A8 WO2004022657 A8 WO 2004022657A8 EP 0309788 W EP0309788 W EP 0309788W WO 2004022657 A8 WO2004022657 A8 WO 2004022657A8
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- mucous membranes
- resorption
- increasing
- via skin
- substances via
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Oncology (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Abstract
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2004533464A JP2005537328A (ja) | 2002-09-04 | 2003-09-03 | 皮膚および粘膜を介した物質の吸収の増大 |
US10/526,846 US20070172516A1 (en) | 2002-09-04 | 2003-09-03 | Increasing of the resorption of substances via skin and mucous membranes |
AU2003273817A AU2003273817A1 (en) | 2002-09-04 | 2003-09-03 | Increasing of the resorption of substances via skin and mucous membranes |
CA002497696A CA2497696A1 (en) | 2002-09-04 | 2003-09-03 | Increasing the absorption of substances via the skin and mucous membranes |
EP03757780A EP1534315A2 (de) | 2002-09-04 | 2003-09-03 | Verstarkung der resorption von substanzen über die haut und schleimhaut |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10240894A DE10240894A1 (de) | 2002-09-04 | 2002-09-04 | Verstärkung der Resorption von Subtanzen über die Haut und Schleimhaut |
DE10240894.7 | 2002-09-04 |
Publications (3)
Publication Number | Publication Date |
---|---|
WO2004022657A2 WO2004022657A2 (de) | 2004-03-18 |
WO2004022657A8 true WO2004022657A8 (de) | 2004-04-22 |
WO2004022657A3 WO2004022657A3 (de) | 2004-09-02 |
Family
ID=31502367
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2003/009788 WO2004022657A2 (de) | 2002-09-04 | 2003-09-03 | Verstärkung der resorption von substanzen über die haut und schleimhaut |
Country Status (7)
Country | Link |
---|---|
US (1) | US20070172516A1 (de) |
EP (1) | EP1534315A2 (de) |
JP (1) | JP2005537328A (de) |
AU (1) | AU2003273817A1 (de) |
CA (1) | CA2497696A1 (de) |
DE (1) | DE10240894A1 (de) |
WO (1) | WO2004022657A2 (de) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8354116B2 (en) * | 2007-06-18 | 2013-01-15 | Biochemics, Inc. | Bifunctional synthetic molecules |
WO2024004159A1 (ja) * | 2022-06-30 | 2024-01-04 | Eps創薬株式会社 | 舌下投与用ワクチン組成物 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4545985A (en) * | 1984-01-26 | 1985-10-08 | The United States Of America As Represented By The Secretary, Dept. Of Health And Human Services | Pseudomonas exotoxin conjugate immunotoxins |
DE3584486D1 (de) * | 1984-02-08 | 1991-11-28 | Cetus Corp | Toxinkonjugate. |
EP0566135A1 (de) * | 1992-04-17 | 1993-10-20 | Takeda Chemical Industries, Ltd. | Transmucosale Zubereitungen enthaltend ein Peptid und ein Cytidinderivat |
US5766620A (en) * | 1995-10-23 | 1998-06-16 | Theratech, Inc. | Buccal delivery of glucagon-like insulinotropic peptides |
JP2002511885A (ja) * | 1997-07-24 | 2002-04-16 | ザ パーキン―エルマー コーポレーション | 脂質膜を横切る輸送のための膜透過性構築物 |
DE19850718C1 (de) * | 1998-11-03 | 2000-05-18 | Hildt Eberhardt | Zellpermeabilität-vermittelndes Polypeptid |
DE19904800C1 (de) * | 1999-02-05 | 2001-02-08 | Eberhard Hildt | Partikel zur Gentherapie |
US6887462B2 (en) * | 2001-04-09 | 2005-05-03 | Chiron Corporation | HSA-free formulations of interferon-beta |
US6835810B2 (en) * | 2002-05-13 | 2004-12-28 | Geneshuttle Biopharma, Inc. | Fusion protein for use as vector |
-
2002
- 2002-09-04 DE DE10240894A patent/DE10240894A1/de not_active Ceased
-
2003
- 2003-09-03 EP EP03757780A patent/EP1534315A2/de not_active Withdrawn
- 2003-09-03 WO PCT/EP2003/009788 patent/WO2004022657A2/de active Application Filing
- 2003-09-03 JP JP2004533464A patent/JP2005537328A/ja active Pending
- 2003-09-03 AU AU2003273817A patent/AU2003273817A1/en not_active Abandoned
- 2003-09-03 CA CA002497696A patent/CA2497696A1/en not_active Abandoned
- 2003-09-03 US US10/526,846 patent/US20070172516A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU2003273817A8 (en) | 2004-03-29 |
EP1534315A2 (de) | 2005-06-01 |
AU2003273817A1 (en) | 2004-03-29 |
JP2005537328A (ja) | 2005-12-08 |
WO2004022657A2 (de) | 2004-03-18 |
WO2004022657A3 (de) | 2004-09-02 |
CA2497696A1 (en) | 2004-03-18 |
US20070172516A1 (en) | 2007-07-26 |
DE10240894A1 (de) | 2004-03-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2004006858A3 (en) | Compounds, compositions, and methods employing same | |
AU2003303458A1 (en) | Ampholytic copolymer and use thereof | |
WO2005011592A3 (en) | Substituted indazole-o-glucosides | |
EP2311488A3 (de) | Impfstoffzusammensetzung | |
WO2005012243A3 (en) | Substituted indole-o-glucosides | |
WO2005012242A3 (en) | Substituted benzimidazole-, benztriazole-, and benzimidazolone-o-glucosides | |
IL173059A0 (en) | (2s,4s)-4-fluoro-1-[4-fluoro-beta-(4-fluorophenyl)-l-phenylalanyl]-2-pyrrolidinecarbonitrile p-toluenesulfonic acid salt and anhydrous crystalline forms thereof | |
WO2004041203A3 (en) | Gemcitabine prodrugs, pharmaceutical compositions and uses thereof | |
AU2003254898A1 (en) | Fragrance composition | |
AU2003246810A1 (en) | Diphenylpyridine derivatives, the preparation thereof, and pharmaceutical compositions containing said derivatives | |
WO2004069152A3 (en) | Δ4,5 glycuronidase and uses thereof | |
WO2005046603A3 (en) | Pyridine compounds | |
PL374080A1 (en) | Processes for the preparation of fibrinogen | |
WO2003099192A8 (en) | Bis-aromatic alkanols | |
AU2003201595A1 (en) | Fragrance compositions | |
AU2003294785A1 (en) | Hair treatment compositions | |
WO2004031202A3 (de) | Kondensierte palatinose in hydrierter form | |
EP1944027A4 (de) | Pharmazeutische zusammensetzung zur behandlung oder prävention von nephritis und herstellungsverfahren dafür | |
WO2000040232A3 (en) | Bretylium compositions and kits, and their use in preventing and treating cardiovascular conditions | |
AU2003211610A1 (en) | Pharmaceutical compositions for the treatment or prevention of osteoporosis | |
WO2006055663A3 (en) | The use of novel antibacterial compounds | |
WO2005060981A3 (en) | Pharmaceutical compositions | |
WO2004022657A8 (de) | Verstärkung der resorption von substanzen über die haut und schleimhaut | |
WO2004105705A8 (en) | Hair treatment compositions | |
WO2004078142A3 (en) | Compositions and methods for preventing and treating endotoxin-related diseases and conditions |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
CFP | Corrected version of a pamphlet front page | ||
CR1 | Correction of entry in section i |
Free format text: IN PCT GAZETTE 12/2004 REPLACE "A1" BY "A2" AND UNDER "PUBLISHED", REPLACE "WITH INTERNATIONAL SEARCH REPORT" BY "WITHOUT INTERNATIONAL SEARCH REPORT" |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
CFP | Corrected version of a pamphlet front page | ||
CR1 | Correction of entry in section i |
Free format text: IN PCT GAZETTE 12/2004 REPLACE "A1" BY "A2" AND UNDER "PUBLISHED", REPLACE "WITH INTERNATIONAL SEARCH REPORT" BY "WITHOUT INTERNATIONAL SEARCH REPORT" |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2003757780 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2497696 Country of ref document: CA Ref document number: 2004533464 Country of ref document: JP |
|
WWP | Wipo information: published in national office |
Ref document number: 2003757780 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2007172516 Country of ref document: US Ref document number: 10526846 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 10526846 Country of ref document: US |